KKR-backed IVI RMA and GED Capital completed the acquisition of Eugin Group from Fresenius for €500m.

KKR-backed IVI RMA, a clinic that specializes in human reproduction, developing reproductive medicine, and GED Capital, an independent private equity group, completed the acquisition of Eugin Group, a fertility center group that provides customized solutions and services for assisted reproduction, from Fresenius, a global health care group, for €500m. “We are thrilled to add Eugin’s operations in the US and Canada to the IVI RMA group. Our ethos of compassionate, personalized care will help ensure we deliver a world-class patient experience and successful outcomes for more patients. We are pleased to have partnered with GED in this creative transaction. We’re confident that our shared vision and complementary strengths make this partnership greater than the sum of its parts, allowing IVI RMA to continue its growth in North America and GED to invest behind a leading platform in Europe and Latin America,” Javier Sanchez Prieto, IVI RMA CEO.